• 1
    Bensinger, W.I., Appelbaum, F.R., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffmann, K., Weaver, C., Clift, R., Chauncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R., Buckner, C.D. (1995) Factors that influence collection and engraftment of autologous peripheral stem cells. Journal of Clinical Oncology, 13, 2547 2555.
  • 2
    Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chauncey, T., Storb, R., Buckner, C.D. (1994) Peripheral blood stem cells collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology, 87, 825 831.
  • 3
    Chao, N.J., Schriber, J.R., Griomes, K., Long, G.D., Negrin, R.S., Raimondi, C.M., Horning, S.J., Brown, S.L., Miller, L., Blume, K.G. (1993) Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood, 81, 2031 2035.
  • 4
    Craig, W., Kay, R., Cutler, R.L., Lansdorp, P.M. (1993) Expression of Thy-1 on human hematopoietic progenitor cells. Journal of Experimental Medicine, 177, 1331 1342.
  • 5
    Demirer, T., Buckner, C.D., Gooley, T., Appelbaum, F.R., Rowley, S., Chauncey, T., Lilleby, K., Storb, R., Bensinger, W.I. (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplantation, 17, 937 941.
  • 6
    Dreger, P., Klöss, M., Petersen, B., Haferlach, T., Löffler, H., Schmitz, N. (1995) Autologous progenitor cell transplantation: prior exposure to stem cell toxic drugs determines yield and engraftment of peripheral blood progenitor cells but not of bone marrow cells. Blood, 86, 3970 3978.
  • 7
    Dreger, P., Marquardt, P., Haferlach, T., Jabobs, S., Mulverstedt, T., Eckstein, V., Suttorp, M., Löffler, H., Müller-Ruchholtz, W., Schmitz, N. (1993) Effective mobilization of peripheral blood progenitor cells with Dexa-BEAM and G-CSF: timing of harvesting and composition of the leukapheresis product. British Journal of Cancer, 68, 950 957.
  • 8
    Gianni, A.M., Siena, S., Bregni, S., Stern, C., Tarella, C., Pileri, A., Bonnadonna, G. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet, ii, 540 544.
  • 9
    Goldschmidt, H., Hegenbart, U., Haas, R., Hunstein, W. (1996) Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte stimulating factor in patients with multiple myeloma . Bone Marrow Transplantation, 17, 691 697.
  • 10
    Haas, R., Moos, M., Karcher, R., Möhle, R., Witt, B., Goldschmidt, H., Frühauf, S., Flentiji, M., Wannenmacher, M., Hunstein, W. (1994) Sequential high-dose therapy with peripheral blood progenitor cell support in low grade non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 1685 1692.
  • 11
    Haioun, C., Lepage, E., Gisselbrecht, C., Basson, Y., Coiffier, B., Brice, P., Bosly, A., Duprice, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Goulard, P., Reyes, F. (1997) Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor risk aggressive non Hodgkin's lymphoma: update results of the prospective study LNH87-2. Journal of Clinical Oncology, 15, 1131 1131.
  • 12
    Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L. (1994) A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361 1392.
  • 13
    Hassan, H.T., Krog, C., Stockschläder, M., Zeller, W., Krüger, W., Erttmann, R., Zander, A.R. (1997) Factors influencing the haematological recovery after allogenic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GvHD prophylaxis: a single centre experience. Supportive Care Cancer, 57, 299 306.
  • 14
    Hassan, H.T., Zeller, W., Schleimer, B., Stockschläder, M., Krüger, W., Hoffknecht, M.M., Zander, A.R. (1996a) CD34 positive cell selection using CellPro Ceprate in 55G-CSF mobilised peripheral blood grafts collected for transplantation. Bone Marrow Transplantation, 17, (Suppl. 1), 245.
  • 15
    Hassan, H.T., Zeller, W., Stockschläder, M., Krüger, W, Hoffknecht, M.M., Zander, A.R. (1996) Comparison between bone marrow and G-CSF mobilized blood allograft undergoing clinical scale CD34 positive cell selection. Stem Cells, 14, 419 429.
  • 16
    Horning, S.J., Negrin, R.S., Chao, N.J., Long, G.D., Hoppe, R.T., Blume, K.G. (1994) Fractionated total body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 2552 2558.
  • 17
    Jones, H.M., Jones, S.A., Watts, M.J., Khwaja, H., Mills, W., Fielding, J., Goldstone, A.H., Linch, D.C. (1994) Development of a simplified single apheresis approach for peripheral-blood progenitor cell transplantation in previously treated patients with lymphoma. Journal of Clinical Oncology, 12, 1693 1702.
  • 18
    Kessinger, M., Bierman, P.J., Vose, J.M., Armitage, J.O. (1991) High dose cyclophosphamide, carmustine and etoloside followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease. Blood, 77, 2322 2325.
  • 19
    Lennert, K. & Feller, A.C. (1990) Histopathologie der Non-Hodgkin Lymphome. Springer, Berlin.
  • 20
    Mahe, B., Milpied, N., Hermouet, S., Robillard, N., Moreau, P., Letortorec, S., Rapp, M.J., Bataille, R., Harousseau, J.L. (1996) G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma and lymphoma. British Journal of Haematology, 92, 263 268.
  • 21
    McQuaker, I.G., Haynes, A.P., Stainer, C., Anderson, S., Russell, N.H. (1997) Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, eoposide and epirubicin compared to intermediate-dose cyclophosphamide. British Journal of Haematology, 98, 228 233.
  • 22
    Möhle, R., Pfoersich, M., Fruehauf, S., Witt, B., Krämer, A., Haas, R. (1994) Filgrastim postchemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with the use during steady-state hematopoiesis. Bone Marrow Transplantation, 14, 827 832.
  • 23
    Nademanee, A., Sniecinski, I., Schmidt, G.M., Dagis, A.C., O'Donnell, M.R., Snyder, D.S., Parker, P.M., Stein, A.S., Smith, E.P., Molina, R., Stepan, D.E., Somlo, G., Margolin, K.A., Wood, D., Niland, J.C., Forman, S.J. (1994) High-dose therapy followed by autologous peripheral blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin' lymphoma using unprimed and granulocyte colony stimulating factor mobilized peripheral stem cells. Journal of Clinical Oncology, 12, 2176 2186.
  • 24
    Pettengell, R., Testa, N.G., Schwindell, R., Crowther, D., Dexter, T.M. (1993) Transplantation potential of hematopoietic cells released into circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood, 82, 2239 2248.
  • 25
    Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F., Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses in chemosensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540 1545.
  • 26
    Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Booggerts, M.A., Ferrant, A., Demuynck, H.M.S., Zander, A.R., Borkett, K. (1996) A randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet, 347, 3563 3567.
  • 27
    Schwartzberg, L.S., Birch, R., Hazelton, B. (1992) Peripheral blood stem cell mobilization by chemotherapy with or without recombinant human granulocyte colony stimulating factor. Journal of Hematotherapy, 1, 317 327.
  • 28
    Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G., Fox, R.M. (1992) Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640 644.
  • 29
    Siena, S., Bregni, M., Brando, B., Ravagnani, F., Bonnadonna, G., Ganni, A.M. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400 409.
  • 30
    Terstappen, L.W.M.M., Huang, S., Safford, M., Lansdord, P.M., Loken, M.R. (1991) Sequential generations of hematopoietic colonies derived from single non-lineage-committed CD34+ CD38 progenitor cells. Blood, 77, 1218 1227.
  • 31
    To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Banford, A.L., Thorp, D., Ho, J.Q.K., Dart, G.W., Horvarth, N., Davy, M.L.J., Olweny, C.L.M., Abdi, E., Juttner, C.A. (1992) Comparison of hematological recovery times and supportive care requirements for autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogenic bone marrow transplants. Bone Marrow Transplantation, 9, 277 284.
  • 32
    Weaver, C.H., Hazelton, B., Birsh, R., Palmer, P., Allen, C., Schwartzberg, L., West, W. (1995) An analysis of engraftement kinetics as a function of the CD34 content of peripheral blood progenitor cell collection in 692 patients after administration of myeloablative chemotherapy. Blood, 86, 3961 3969.
  • 33
    Zeller, W., Gutensohn, K., Stockschläder, M., Dierlamm, J., Kröger, N., Köhne, G., Hummel, K., Kabisch, H., Weh, H.J., Kühnl, P., Hossfled, D.K., Zander, A.R. (1996) Increase of mobilized CD34 positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplantation, 17, 709 713.